Korean name: 강황추출물. This page reports what South Korea's
Ministry of Food and Drug Safety has approved for this ingredient.
MFDS recognition no.
2023-5
Approval route
Notified (고시형) — listed in MFDS public standards
Daily intake (as approved)
100.0–250.0 mg/ 일
Approval holder
(주)아리바이오
Approved functional claim (Korean original)
The text below is the approved wording as published by MFDS. It is reproduced without
modification. Any translation is provided for comprehension only and carries no regulatory
standing.
근력개선에 도움을 줄 수 있음
Precautions (Korean original)
∎ 영유아, 임산부, 수유부 및 특정질환(담낭질환, 출혈질환)이 있는 분은 섭취에 주의하시기 바랍니다.∎ 강황에 대한 특이체질 및 알러지 체질의 경우 성분을 확인하고 섭취하시기 바랍니다.∎ 제안된 섭취량 이상 섭취시 소화불량, 위장장애, 메스꺼움, 위산 역류 등이 있을 수 있습니다.⇒ 신청원료의 인체적용시험 대상자에 영유아, 임산부, 수유부 및 특정질환자 등은 포함되지 않았으므로, 섭취 시 주의사항으로 설정⇒ 강황뿌리줄기에 대한 독성학적 보고나 이상 반응은 보고되지 않았으나 강황은 항응고작용과 담즙분비를 촉진작용을 하여 섭취시 주의사항으로 설정
What this means for sourcing
An ingredient approved in Korea is not automatically permitted elsewhere. Importers should
verify status with their own authority. Conversely, Korean approval demonstrates that a dossier
on safety and function was reviewed under a national regulatory system, which many buyers treat
as a meaningful signal.
Regulatory approvals described on this page were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts; it does not recommend or endorse any product.